Related Experiment Video
Updated: Feb 14, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Emerging role of RUNX3 in the regulation of tumor microenvironment
Sarala Manandhar1, You Mie Lee1
1Laboratory of Vascular Homeostasis Regulation, BK21 Plus KNU Multi-Omics based Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu 41566, Korea.
Abstract:
A number of genes have been therapeutically targeted to relieve cancer, but cancer relapse is still a growing issue. The concept that the surrounding tumor environment is critical for the progression of cancer may foster an answer to the issue of cancer malignancy. Runt domain transcription factors (RUNX1, 2, and 3) are evolutionarily conserved and have been intensively studied for their roles in normal development and pathological conditions. During tumor growth, a hypoxic microenvironment and infiltration of the tumor by immune cells are common phenomena. In this review, we briefly introduce the consequences of hypoxia and immune cell infiltration into the tumor microenvironment with a focus on RUNX3 as a critical regulator. Furthermore, based on our current knowledge of the functional role of RUNX3 in hypoxia and immune cell maintenance, a probable therapeutic intervention is suggested for the effective management of tumor growth and malignancy. [BMB Reports 2018; 51(4): 174-181].
Insights
Cancer relapse remains a challenge, but the tumor microenvironment offers potential solutions. RUNX3, a transcription factor, is a key regulator in hypoxic and immune-infiltrated tumors, suggesting new therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Cancer therapeutic targeting faces challenges due to relapse.
- The tumor microenvironment (TME) significantly influences cancer progression and malignancy.
- Runt domain transcription factors (RUNX1, 2, and 3) are crucial in development and disease.
Purpose of the Study:
- To review the impact of hypoxia and immune cell infiltration in the TME.
- To highlight RUNX3 as a critical regulator within the TME.
- To propose therapeutic interventions targeting RUNX3 for cancer management.
Main Methods:
- Literature review focusing on hypoxia, immune cells, and RUNX3.
- Analysis of the functional roles of RUNX3 in the TME.
- Synthesis of current knowledge to suggest therapeutic strategies.
Main Results:
- Hypoxia and immune cell infiltration are common in tumors.
- RUNX3 plays a critical role in regulating the TME under these conditions.
- Understanding RUNX3's function provides insights into tumor growth and malignancy.
Conclusions:
- RUNX3 is a key regulator influenced by hypoxia and immune cells in the TME.
- Targeting RUNX3 presents a potential therapeutic avenue for managing cancer growth and malignancy.
- Further research into RUNX3's role can lead to effective cancer treatments.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Emerging Adulthood
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Introduction Cardiac Emergencies
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Epigenetic Regulation

